Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 USD | +0.65% | +15.64% | +45.10% |
04-10 | Transcript : Chemomab Therapeutics Ltd. - Special Call | |
03-07 | Chemomab Therapeutics Ltd. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adi Mor
CEO | Chief Executive Officer | 43 | 11-09-21 |
Sigal Fattal
DFI | Director of Finance/CFO | 53 | 19-12-31 |
Chief Tech/Sci/R&D Officer | 56 | 22-11-13 | |
Ilan Vaknin
CTO | Chief Tech/Sci/R&D Officer | - | 22-08-11 |
Jack Lawler
CTO | Chief Tech/Sci/R&D Officer | - | 22-01-03 |
Barbara Lindheim
IRC | Investor Relations Contact | - | - |
Sharon Hashmueli
LAW | General Counsel | - | 15-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Cohen
BRD | Director/Board Member | 60 | 20-03-31 |
Nissim Darvish
CHM | Chairman | 59 | 21-03-15 |
Claude Nicaise
BRD | Director/Board Member | 71 | 21-03-15 |
Alan Moses
BRD | Director/Board Member | 76 | 21-03-15 |
Adi Mor
CEO | Chief Executive Officer | 43 | 11-09-21 |
Jill Quigley
BRD | Director/Board Member | 48 | 22-06-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 20 | 14,204,735 | 705,422 ( 4.966 %) | 0 | 4.966 % |
Company contact information
Chemomab Therapeutics Ltd.
Kiryat Atidim Building 7
6158002, Tel Aviv
+972 77 331 0156
http://www.chemomab.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+45.10% | 10.51M | |
+8.96% | 105B | |
-1.43% | 104B | |
+5.24% | 22.94B | |
-12.15% | 22.34B | |
-6.87% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |
- Stock Market
- Equities
- CMMB Stock
- Company Chemomab Therapeutics Ltd.